Item 5.07. Submission of Matters to a Vote of Security Holders.
In order to support the health and well-being ofHCA Healthcare, Inc.'s (the "Company's") stockholders, employees and community due to the impact of the COVID-19 pandemic, the Company held its Annual Meeting of Stockholders (the "Annual Meeting") onApril 28, 2021 in a virtual meeting format only, via webcast. At the Annual Meeting, a total of 308,314,735 shares of our common stock, out of a total of 336,936,865 shares of common stock outstanding and entitled to vote, were represented in person or by proxy. Voting results from the Annual Meeting were as follows: 1. The following nine director nominees were elected to the Company's Board of Directors for a one-year term, or until such director's respective successor is duly elected and qualified or such director's earlier death, resignation or removal, as follows: For Against Abstentions Broker Non-Votes Thomas F. Frist III 285,519,060 6,020,841 630,805 16,144,029 Samuel N. Hazen 290,889,075 651,378 630,253 16,144,029 Meg G. Crofton 290,867,743 665,357 637,606 16,144,029 Robert J. Dennis 286,178,869 5,349,768 642,069 16,144,029 Nancy-Ann DeParle 284,708,899 6,825,150 636,657 16,144,029 William R. Frist 290,180,394 1,336,162 654,150 16,144,029 Charles O. Holliday, Jr. 269,231,973 21,611,847 1,326,886 16,144,029 Michael W. Michelson 290,108,255 1,400,530 661,921 16,144,029 Wayne J. Riley, M.D. 286,377,487 5,157,310 635,909 16,144,029 2. The selection ofErnst & Young LLP as the Company's independent registered public accounting firm for the year endingDecember 31, 2021 was ratified as follows: For Against Abstentions Broker Non-Votes 289,047,637 18,646,258 620,840 0
3. The adoption of a non-binding advisory resolution on the Company's named executive officer compensation as described in the Company's 2021 proxy statement was approved as follows:
For Against Abstentions Broker Non-Votes 280,813,046 10,403,853 953,807 16,144,029 4. The stockholder proposal regarding stockholders' ability to act by written consent as described in the Company's 2021 proxy statement was not approved as follows: For Against Abstentions Broker Non-Votes 65,388,322 225,643,421 1,138,963 16,144,029
5. The stockholder proposal requesting a report on the feasibility of increasing the impact of quality metrics on executive compensation as described in the Company's 2021 proxy statement was not approved as follows:
For Against Abstentions Broker Non-Votes 28,463,199 261,741,413 1,966,094 16,144,029
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits: Exhibit No. Description Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
--------------------------------------------------------------------------------
© Edgar Online, source